| Identification | Back Directory | [Name]
OTAVA-BB 1217676 | [CAS]
120711-81-1 | [Synonyms]
OTAVA-BB 1217676 7-Nitro-3,4-dihydrobenzo[1,4]oxazine 7-Nitro-3,4-dihydro-2H-1,4-benzoxazine 7-Nitro-3,4-dihydro-2H-1,4-benzooxazine 7-Nitro-3,4-dihydro-2H-benzo[1,4]oxazine 2H-1,4-Benzoxazine, 3,4-dihydro-7-nitro- 7-Nitro-3,4-dihydro-2H-1,4-benzoxazine,97% 3,4-Dihydro-7-nitro-2H-benzo[b][1,4]oxazine 7-NITRO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE | [Molecular Formula]
C8H8N2O3 | [MDL Number]
MFCD11603433 | [MOL File]
120711-81-1.mol | [Molecular Weight]
180.162 |
| Chemical Properties | Back Directory | [Melting point ]
187-188° | [Boiling point ]
341.6±42.0 °C(Predicted) | [density ]
1.332±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Inert atmosphere,Room temperature | [pka]
0.23±0.20(Predicted) | [Appearance]
Light yellow to yellow Solid | [Water Solubility ]
Sparingly soluble in water (0.76 g/L at 25°C). | [CAS DataBase Reference]
120711-81-1 |
| Safety Data | Back Directory | [Symbol(GHS) ]
 GHS06 | [Signal word ]
Danger | [Hazard statements ]
H301 | [Precautionary statements ]
P301+P310 | [Hazard Codes ]
T | [Risk Statements ]
25 | [Safety Statements ]
45 | [RIDADR ]
UN 2811 6.1 / PGIII | [HazardClass ]
IRRITANT | [HS Code ]
2934999090 |
| Hazard Information | Back Directory | [Uses]
7-Nitro-3,4-dihydro-2H-1,4-benzooxazine can be used as pain drugs to prevent and treat chronic pain. | [Synthesis]
The general procedure for the synthesis of 7-nitro-3,4-dihydro-2H-1,4-benzisoxazin-3-one from 7-nitro-2H-1,4-benzisoxazin-3-one was as follows: 7-nitro-4H-benzo[1,4]oxazin-3-one (2.00 g, 10.3 mmol) was dissolved in tetrahydrofuran (THF, 10 mL), and borane-THF complex was added subsequently ( 1.0 M solution of THF, 35 mL). The reaction mixture was heated to reflux for 30 min, then cooled to 0 °C and the reaction was quenched with 1 N hydrochloric acid (20 mL). After continued stirring for 30 min, the reaction solution was concentrated to 1/10 of the original volume. the orange solid product was collected by filtration, washed with water and dried under vacuum to afford 7-nitro-3,4-dihydro-2H-1,4-benzisoxazine (1.66 g, 89% yield). The mass spectrum (electrospray positive ion mode) showed m/z 181.1 ([M+H]+) and the mass spectrum (electrospray negative ion mode) showed m/z 179.2 ([M-H]-).1H NMR (400 MHz, DMSO-d6) data were as follows: δ 7.68 (dd, 1H, J = 8.8, 2.6 Hz), 7.53 (s, 1H), 7.47 (d , 1H, J = 2.6 Hz), 6.63 (d, 1H, J = 9.2 Hz), 4.15 (t, 2H, J = 4.4 Hz), 3.44-3.40 (m, 2H). | [References]
[1] Journal of Medicinal Chemistry, 2007, vol. 50, # 10, p. 2486 - 2496 [2] Patent: WO2006/66174, 2006, A1. Location in patent: Page/Page column 52-53 [3] Patent: US2010/9975, 2010, A1. Location in patent: Page/Page column 35 [4] Journal of the American Chemical Society, 2014, vol. 136, # 38, p. 13277 - 13282 [5] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 13, p. 3821 - 3830 |
|
| Company Name: |
Alfa Aesar
|
| Tel: |
400-6106006 |
| Website: |
http://chemicals.thermofisher.cn |
| Company Name: |
SynAsst Chemical.
|
| Tel: |
021-60343070 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList15848/0_EN.htm |
|